NKTR   $0.454  -8.46% Market Closed

Nektar Therapeutics
Total Cash 303.62M
totalCashPerShare 1.654
EBITDA -127.41M
Total Debt 117.78M
quickRatio 5.966
currentRatio 6.45
Total Revenue 90.12M
debtToEquity 89.914
Revenue/Share 0.474
ROA -0.15247
ROE -1.1094899
grossProfits
freeCashflow -63.63M
operatingCashflow -192.61M
earningsGrowth
revenueGrowth 0.085
grossMargins 0.62531
ebitdaMargins -1.41375
operatingMargins -1.28365
profitMargins 0.0
enterpriseValue -14.30M
forwardPE -1.3157747
floatShares 163.11M
sharesOutstanding 183.62M
sharesShort 2.51M
sharesShortPriorMonth 2.45M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.67%
Short Ratio help_outline 0.93%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.684
Price To Book help_outline 1.37
earningsQuarterlyGrowth
netIncomeToCommon -276.06M
trailingEps -1.45%
forwardEps -0.71%
enterpriseToEbitda 0.11
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.19 1Q 2024
institutionsCount 155
lastUpdated April 1, 2024, 11:21 a.m.